ACW 4.05% 7.1¢ actinogen medical limited

Ann: Positive Xanamem biomarker trial published in Jnl Alz Dis, page-74

  1. 489 Posts.
    lightbulb Created with Sketch. 5
    There is no way that ACW can be cashed up till late 2025 without existing unlisted options being exercised. This is also a reason as to why a pullback/retracement will occur as well. They still need a sizeable amount of cash to fund the remaining AZ non Australian trial extension which is after the projected interim analysis mid 2025.

    This what I posted. Read the first line!




 
watchlist Created with Sketch. Add ACW (ASX) to my watchlist
(20min delay)
Last
7.1¢
Change
-0.003(4.05%)
Mkt cap ! $191.2M
Open High Low Value Volume
7.3¢ 7.9¢ 6.9¢ $1.067M 14.27M

Buyers (Bids)

No. Vol. Price($)
1 307386 7.1¢
 

Sellers (Offers)

Price($) Vol. No.
7.4¢ 76342 1
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
ACW (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.